Safety and efficacy of ofatumumab, a fully human monoclonal anti-CD20 antibody, in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: a phase 1-2 study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples